Patients Diabetes (Type 2)
Topic of the discussion
Posted on 7/20/18 12:26 PM
A new study, published in the journal BMJ, finds that switching to a class of drugs called sulfonylureas could raise the risk of complications for people living with type 2 diabetes.
Researchers set out to investigate how safe it is for patients with type 2 diabetes to switch from taking metformin, which is a standard "first-line" antidiabetic drug, to taking sulfonylureas, often prescribed to control blood sugar levels when metformin alone fails.
They were led by Prof. Samy Suissa, from McGill University in Quebec, Canada.
As Prof. Suissa and colleagues explain in their paper, numerous studies have confirmed the safety of sulfonylureas.
Fewer, however, have focused on their safety when patients have switched to the drugs or when they have added them to their previous treatment.
So, to fill this research gap, the scientists examined whether adding sulfonylureas or switching to them from metformin raises the risk of cardiovascular problems such as heart attack or stroke, or the risk of death from cardiovascular problems or from any other causes.
Also, the team examined whether or not switching to, or adding, sulfonylureas raised the risk of severe hypoglycemia, or low blood sugar. All these risks were compared with taking metformin alone.
Continuing metformin safer than switching
In order to study these links, the researchers examined over 77,138 people with type 2 diabetes who started taking metformin between 1998 and 2013.
Of these, 25,699 either added sulfonylureas to their treatment or switched to them altogether during the study period.
The team compared these people with age-matched controls who continued to take only metformin over a follow-up period of 1.1 years, on average.
Overall, when compared with staying on metformin, the study found that adding, or switching to, sulfonylureas was linked with a higher risk of a heart attack, death from any causes, and severe hypoglycemia.
More specifically, people adding, or switching to, the second-line treatment were 26 percent more likely to have a heart attack, 28 percent more likely to die from any causes, and over seven times more likely to have severe hypoglycemia, on average.
The researchers also discovered a trend toward a higher likelihood of stroke and death from heart problems in those switching to, or adding, sulfonylureas.
Finally, when comparing just adding sulfonylureas to metformin with switching to sulfonylureas completely, the latter raised the risk of a heart attack by 51 percent and mortality from all causes by 23 percent.
However, no differences were found in the risk of stroke, cardiovascular death, or hypoglycemia between just adding the drugs and switching to them.
Prof. Suissa and colleagues conclude, "Sulfonylureas as second-line drugs are associated with an increased risk of myocardial infarction, all-cause mortality, and severe hypoglycemia, compared with remaining on metformin monotherapy."
As with any observational study, causality cannot be inferred from the results. But researchers Lucy D'Agostino McGowan and Christianne Roumie deem the study "well designed and the relations [...] strong and consistent" in an accompanying editorial, which is also published in the BMJ.
Medical News Today
Beginning of the discussion - 7/31/18Diabetes: Switching to common drugs raises risk of complications https://www.carenity.co.uk/forum/diabetes-type-2/my-library-type-2-diabetes/diabetes-switching-to-common-drugs-raises-risk-of-complications-2485
Posted on 7/31/18 12:45 AM
'Finds that switching to a class of drugs called sulfonylureas could raise the risk of complications for people living with type 2 diabetes'. If this is the case that further complications are know then doctors should not prescribe them unless it is a 'last chance' scenario. Us diabetics have enough problems to think about as it is.
Surely knowing the possible added side effects, the drugs should not even be considered as an addition or replacement if the current medication regime is working? There are enough conditions around that can cause cardiovascular problems without adding to the list.
Posted on 8/4/18 11:07 AM
One of the side effects of metformin is extended life expectancy a consultant assured me. She stated whatever happens keep up with my metformin and I will get a few extra years so always ensure I take it whatever other drugs I get added!
Posted on 8/6/18 4:08 PM
That is ok but many can not take metformin because of alwful sde efets
Posted on 8/6/18 4:10 PM
Sorry side effects
Posted on 8/21/18 12:47 AM
'One of the side effects of Metformin is extended life expectancy.....' I've not heard that one.
I think I'll do some research and get back to you.
Does this topic interest you?
Join 150 000 patients registered on our platform, get information on your condition or on that of your family member, and discuss it with the communityJoin
It’s free and confidential